Key Takeaways Starting dose: 2mg once weekly for the first 4 weeks to assess tolerance Titration schedule: Increase every 4 weeks: 2mg 4mg 8mg 12mg (max) Half-life: Approximately 6 days, reaching steady state in 4-5 weeks Injection frequency: Once weekly on the same day each week Microdosing option: Some users split doses for improved tolerability Investigational Drug: Retatrutide is NOT FDA-approved and is currently only available through clinical trials
Attempting to lose weight beyond a healthy range can lead to nutrient deficiencies, muscle loss, bone density issues, and other adverse health outcomes, as well as potentially fostering unhealthy relationships with food and body image
(2021) employed exenatide extended-release 2 mg once weekly as the formulary option in their institution, with only one patient later switched to dulaglutide 0.75 mg weekly
With OnPoint Nutrition, you're supported on a path to a judgement-free healthier, balanced life
Given the challenges with brand-name costs and insurance hurdles, many patients and providers are turning to compounded medications
Molecular Metabolism , 15 , 3544